Minna Taskinen

883 total citations
13 papers, 666 citations indexed

About

Minna Taskinen is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Minna Taskinen has authored 13 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Minna Taskinen's work include Lymphoma Diagnosis and Treatment (11 papers), Immune Cell Function and Interaction (4 papers) and Ubiquitin and proteasome pathways (3 papers). Minna Taskinen is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Immune Cell Function and Interaction (4 papers) and Ubiquitin and proteasome pathways (3 papers). Minna Taskinen collaborates with scholars based in Finland, Sweden and Norway. Minna Taskinen's co-authors include Sirpa Leppä, Marja‐Liisa Karjalainen‐Lindsberg, Heidi Nyman, Carl Blomqvist, Rose‐Marie Amini, Gunilla Enblad, Magdalena Adde, Mattias Berglund, Minna Eriksson and Mats Jerkeman and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Minna Taskinen

13 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minna Taskinen Finland	9	451	327	227	167	127	13	666
Bénédicte Hivert France	10	304 0.7×	211 0.6×	88 0.4×	260 1.6×	177 1.4×	24	606
Majlis Book Sweden	6	178 0.4×	124 0.4×	91 0.4×	89 0.5×	201 1.6×	9	444
Brandy Edenfield United States	11	137 0.3×	333 1.0×	229 1.0×	109 0.7×	146 1.1×	19	624
Brigitte Wollert‐Wulf Germany	7	213 0.5×	169 0.5×	149 0.7×	118 0.7×	209 1.6×	9	538
John Densmore United States	10	257 0.6×	219 0.7×	337 1.5×	202 1.2×	154 1.2×	27	712
Gary McIntosh United Kingdom	8	72 0.2×	249 0.8×	34 0.1×	75 0.4×	191 1.5×	9	491
Jinghua Wang China	12	207 0.5×	228 0.7×	104 0.5×	33 0.2×	405 3.2×	23	665
Nathan De Beule Belgium	11	165 0.4×	170 0.5×	220 1.0×	302 1.8×	252 2.0×	22	747
D Oberberg Germany	12	40 0.1×	186 0.6×	159 0.7×	53 0.3×	145 1.1×	22	499
Juan‐Han Yu China	17	88 0.2×	226 0.7×	81 0.4×	70 0.4×	409 3.2×	62	775

Countries citing papers authored by Minna Taskinen

Since Specialization

Citations

This map shows the geographic impact of Minna Taskinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minna Taskinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minna Taskinen more than expected).

Fields of papers citing papers by Minna Taskinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minna Taskinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minna Taskinen. The network helps show where Minna Taskinen may publish in the future.

Co-authorship network of co-authors of Minna Taskinen

This figure shows the co-authorship network connecting the top 25 collaborators of Minna Taskinen. A scholar is included among the top collaborators of Minna Taskinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minna Taskinen. Minna Taskinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Taskinen, Minna, Riku Louhimo, Ping Chen, et al.. (2014). Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma. PLoS ONE. 9(3). e91031–e91031. 18 indexed citations

Saarinen, Silva, Eevi Kaasinen, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2013). Primary mediastinal large B-cell lymphoma segregating in a family: exome sequencing identifies MLL as a candidate predisposition gene. Blood. 121(17). 3428–3430. 14 indexed citations

Taskinen, Minna, Ping Chen, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2013). Global Profiling Of Outcome Associated Alternative Splicing Events and Gene Expression In Diffuse Large B-Cell Lymphoma. Blood. 122(21). 75–75. 2 indexed citations

Taskinen, Minna, Ping Chen, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2012). Alternative Splicing and Expression of Class II Tubulin Beta (TUBB2B) Are Associated with Outcome in Diffuse Large B-Cell Lymphoma. Blood. 120(21). 1557–1557. 1 indexed citations

Taskinen, Minna, Erkka Valo, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2010). Signal Transducers and Activators of Transcription 5a–Dependent Cross-talk between Follicular Lymphoma Cells and Tumor Microenvironment Characterizes a Group of Patients with Improved Outcome after R-CHOP. Clinical Cancer Research. 16(9). 2615–2623. 6 indexed citations

Taskinen, Minna, Esa Jantunen, Veli‐Matti Kosma, et al.. (2010). Prognostic impact of CD31-positive microvessel density in follicular lymphoma patients treated with immunochemotherapy. European Journal of Cancer. 46(13). 2506–2512. 22 indexed citations

Taskinen, Minna, et al.. (2010). Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy*. European Journal Of Haematology. 86(2). 124–128. 64 indexed citations

Taskinen, Minna, Marja‐Liisa Karjalainen‐Lindsberg, & Sirpa Leppä. (2008). Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. Blood. 111(9). 4664–4667. 58 indexed citations

Nyman, Heidi, Magdalena Adde, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2007). Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood. 109(11). 4930–4935. 223 indexed citations

10.

Taskinen, Minna, et al.. (2007). A High Tumor-Associated Macrophage Content Predicts Favorable Outcome in Follicular Lymphoma Patients Treated with Rituximab and Cyclophosphamide-Doxorubicin-Vincristine-Prednisone. Clinical Cancer Research. 13(19). 5784–5789. 160 indexed citations

11.

Nyman, Heidi, Marja‐Liisa Karjalainen‐Lindsberg, Minna Taskinen, et al.. (2006). Does Rituximab Influence the Prognostic Effect of Germinal Centre Phenotype in Diffuse Large B-Cell Lymphoma?.. Blood. 108(11). 2743–2743. 1 indexed citations

12.

Taskinen, Minna, Matti Nykter, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2006). Differential gene expression in non‐malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP. British Journal of Haematology. 135(1). 33–42. 32 indexed citations

13.

Eriksson, Minna, Minna Taskinen, & Sirpa Leppä. (2006). Mitogen activated protein kinase‐dependent activation of c‐Jun and c‐Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells. Journal of Cellular Physiology. 210(2). 538–548. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact